tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Salim Syed, 208 are a BUY (82.87%), 43 are a HOLD (17.13%).
Analyst Salim Syed, currently employed at MIZUHO, carries an average stock price target met ratio of 59.93% that have a potential upside of 47.61% achieved within 306 days.
Salim Syed’s has documented 488 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASMB, Assembly Biosciences at 01-Sep-2026.
Analyst best performing recommendations are on UBX (UNITY BIOTECHNOLOGY).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) at 7/10/2023. The price target of $29 was fulfilled within 7 days with a profit of $11.64 (67.05%) receiving and performance score of 95.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-May-2019
$480
$40.74 (9.27%)
$450
Hold Since 21-Feb-2026
$400
$-39.26 (-8.94%)
$380
Hold Since 11-Oct-2026
$415
$-24.26 (-5.52%)
$450
13 days ago
(11-Oct-2026)
33/35 (94.29%)
$0.13 (0.03%)
543
Hold Since 09-Jan-2025
$430
$-9.26 (-2.11%)
$435
13 days ago
(11-Oct-2026)
21/22 (95.45%)
$15.13 (3.65%)
343
Buy Since 25-Jan-2026
$470
$30.74 (7.00%)
$430
13 days ago
(11-Oct-2026)
39/40 (97.5%)
$55.13 (13.29%)
755
Which stock is Salim Syed most bullish on?
Which stock is Salim Syed most reserved on?
What Year was the first public recommendation made by Salim Syed?
